搜索临床试验以:Immunosuppression reduction/modification intravenous immunoglobulin
总计1425个结果
-
University of CambridgeUniversity of Oxford招聘中
-
National Taiwan University Hospital未知
-
Centre Hospitalier Universitaire de Pointe-a-Pitre未知
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)尚未招聘
-
University of OxfordUniversity College London Hospitals; CSL Behring; Guy's and St Thomas' NHS Foundation Trust; Liverpool... 和其他合作者完全的
-
Baxalta now part of Shire完全的原发性免疫缺陷病 (PID) | 低丙种球蛋白血症 | 无丙种球蛋白血症芬兰, 瑞典
-
VA Office of Research and DevelopmentUniversity of Colorado, Denver; Memorial Sloan Kettering Cancer Center; Erasmus Medical Center完全的
-
Biotest Pharmaceuticals Corporation完全的
-
Lifefactors Zona Franca, SAS未知
-
University of GiessenHoffmann-La Roche; Astellas Pharma Inc; Heidelberg University; Aventis Pharmaceuticals完全的
-
Maharishi International UniversityMedical College of Wisconsin完全的
-
TakedaTakeda Development Center Americas, Inc.招聘中
-
Hospital Clinic of BarcelonaAstellas Pharma Inc; Fresenius AG终止
-
National Institute of Allergy and Infectious Diseases...完全的
-
Research Institute of Epidemiology, Microbiology...主动,不招人
-
Medical University of ViennaNational Bank of Austria; Biotest Pharma GmbH终止
-
Wake Forest University Health SciencesNational Heart, Lung, and Blood Institute (NHLBI)完全的心脏疾病 | 心血管疾病 | 肥胖 | 代谢综合症 X美国
-
Eunice Kennedy Shriver National Institute of Child...National Center for Research Resources (NCRR)未知
-
NYU Langone HealthLupus Research Alliance完全的
-
University of Texas Southwestern Medical Center撤销
-
University of KhartoumNational Center for Kidney Diseases and Surgery招聘中
-
Baxalta now part of ShireAlzheimer's Disease Cooperative Study (ADCS)完全的
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.完全的慢性炎症性脱髓鞘性多发性神经根神经病美国, 以色列, 加拿大, 西班牙, 捷克语, 克罗地亚, 波兰, 意大利, 塞尔维亚, 德国, 阿根廷, 墨西哥, 火鸡, 英国, 巴西, 法国, 希腊, 斯洛伐克, 哥伦比亚, 丹麦, 挪威, 瑞典
-
Institute for Clinical and Experimental Medicine招聘中
-
University of South FloridaBaxter Healthcare Corporation未知
-
A.O. Ospedale Papa Giovanni XXIIIAferetica - Italy (BO)终止